| Active ingredients | | Date of last message | Type of reason | AM designation |
| Nimodipine | Change notification | 31.10.2025 | Other | Nimotop S |
| Galantamine hydrobromide | Change notification | 31.10.2025 | Other | Galantamine – 1A Pharma 24 mg delayed-release hard capsules |
| Nimodipine | Initial report | 31.10.2025 | Other | Nimotop |
| Galantamine hydrobromide | Change notification | 31.10.2025 | Other | Galantamine – 1A Pharma 16 mg delayed-release hard capsules |
| Sertraline hydrochloride | Initial report | 31.10.2025 | Other | Zoloft 20 mg/ml concentrate for oral solution |
| Ciprofloxacin hydrochloride monohydrate | Change notification | 30.10.2025 | Other | CIPRO BASICS 750 mg film-coated tablets |
| Ciprofloxacin hydrochloride monohydrate | Change notification | 30.10.2025 | Other | CIPRO BASICS 250 mg film-coated tablets |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 30.10.2025 | Other | ATORVASTATIN BASICS 80 mg film-coated tablets |
| Ezetimibe; simvastatin | Change notification | 30.10.2025 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/80 mg tablets |
| Ezetimibe; simvastatin | Change notification | 30.10.2025 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/40 mg tablets |
| Ezetimibe; simvastatin | Change notification | 30.10.2025 | Production problem | EZETIMIB/SIMVA BASICS 10 mg/20 mg tablets |
| Ezetimibe; simvastatin | Change notification | 30.10.2025 | Production problem | EZETIMIBE/SIMVA BASICS 10 mg/10 mg tablets |
| Esomeprazole hemimagnesium | Change notification | 30.10.2025 | Production problem | ESOMEPRAZOLE BASICS 20 mg gastro-resistant hard capsules |
| Esomeprazole hemimagnesium | Change notification | 30.10.2025 | Production problem | ESOMEPRAZOLE BASICS 40 mg gastro-resistant hard capsules |
| Isotretinoin | Change notification | 30.10.2025 | Other | ISOTRETINOIN BASICS 10 mg soft capsules |
| Isophan insulin suspension for injection (Ph.Eur.) | Initial report | 30.10.2025 | Other | Protaphane Penfill 100 IU/ml injection suspension in cylinder ampoule – OP(10x3ml) |
| Flecainide acetate | Change notification | 30.10.2025 | Other | Tambocor |
| Moxifloxacin hydrochloride (Ph.Eur.) ((with information on water content (1:x))) | Change notification | 30.10.2025 | Other | Moxifloxacin Holsten 400 mg film-coated tablets |
| Doxepin hydrochloride (Ph.Eur.) | Initial report | 30.10.2025 | Other | Doxepin 50 Holsten |
| Alprazolam | Change notification | 30.10.2025 | Other | Alprazolam – 1 A Pharma 1 mg tablets |
| Oxcarbazepine | Change notification | 30.10.2025 | Other | Oxcarbazepine – 1 A Pharma 60 mg/ml oral suspension |
| Flutamide | Change notification | 30.10.2025 | Production problem | FLUTA-cell 250 mg tablets |
| Voriconazole | Initial report | 29.10.2025 | Other | VFEND 200 mg film-coated tablets |
| Doxepin hydrochloride (Ph.Eur.) | Change notification | 29.10.2025 | Other | Doxepin 75 Holsten |
| Doxepin hydrochloride (Ph.Eur.) | Change notification | 29.10.2025 | Production problem | Doxepin 25 Holsten |
| Methylphenidate hydrochloride | Change notification | 29.10.2025 | Other | Methylphenidate AL 36 mg prolonged-release tablets |
| Methylphenidate hydrochloride | Change notification | 29.10.2025 | Other | Metiphenal 10 mg modified-release hard capsules |
| Posaconazole | Change notification | 29.10.2025 | Other | Posaconazole AL 40 mg/ml oral suspension |
| Methylphenidate hydrochloride | Change notification | 29.10.2025 | Other | Methylphenidate AL 27 mg prolonged-release tablets |
| Aprepitant | Change notification | 29.10.2025 | Other | Aprepitant AL 80 mg hard capsules |
| Levothyroxine sodium | Change notification | 28.10.2025 | Production problem | L-thyroxine Henning 125 |
| (4′-O-(13)C)Methacetin | Change notification | 28.10.2025 | Production problem | LiMAxetin 4 mg/ml solution for injection |
| Besilesomab | Initial report | 28.10.2025 | Production problem | Scintimun |
| Besilesomab | Initial report | 28.10.2025 | Production problem | Scintimun |
| Levetiracetam | Change notification | 28.10.2025 | Other | Levetiracetam – 1 A Pharma 1500 mg film-coated tablets |
| Olanzapine embonate monohydrate | Initial report | 28.10.2025 | Production problem | ZYPADHERA 210 mg powder and solvent for the preparation of a prolonged-release suspension for injection – OP(483mg+3ml) |
| Paliperidone palmitate | Initial report | 28.10.2025 | Other | Paliperidone AL 25 mg prolonged-release injection suspension in a pre-filled syringe |
| Paliperidone palmitate | Change notification | 28.10.2025 | Other | Paliperidone AL 50 mg depot injection suspension in a pre-filled syringe |
| Olanzapine | Change notification | 28.10.2025 | Production problem | ZYPREXA |
| Fluphenazine decanoate | Change notification | 28.10.2025 | Production problem | Fluphenazine-neuraxpharm D 50 mg/0.5 ml |
| Fluphenazine decanoate | Change notification | 28.10.2025 | Production problem | Fluphenazine-neuraxpharm D 12.5 mg/0.5 ml |
| Fluphenazine decanoate | Change notification | 28.10.2025 | Production problem | Fluphenazine-neuraxpharm D 25 mg/ml |
| Fluphenazine decanoate | Change notification | 28.10.2025 | Production problem | Fluphenazine-neuraxpharm D 100 mg/ml |
| Atomoxetine hydrochloride | Change notification | 28.10.2025 | Production problem | Atomoxetine-neuraxpharm 60 mg hard capsules |
| Atomoxetine hydrochloride | Change notification | 28.10.2025 | Production problem | Atomoxetine-neuraxpharm 10 mg hard capsules |
| Atomoxetine hydrochloride | Change notification | 28.10.2025 | Production problem | Atomoxetine-neuraxpharm 18 mg hard capsules |
| Atomoxetine hydrochloride | Change notification | 28.10.2025 | Production problem | Atomoxetine-neuraxpharm 25 mg hard capsules |
| Atomoxetine hydrochloride | Change notification | 28.10.2025 | Production problem | Atomoxetine-neuraxpharm 40 mg hard capsules |
| Atomoxetine hydrochloride | Change notification | 28.10.2025 | Production problem | Atomoxetine-neuraxpharm 80 mg hard capsules |
| Atomoxetine hydrochloride | Change notification | 28.10.2025 | Production problem | Atomoxetine-neuraxpharm 100 mg hard capsules |
| Haloperidol decanoate | Change notification | 28.10.2025 | Production problem | Haloperidol-neuraxpharm decanoate 50 mg/ml |
| Haloperidol decanoate | Change notification | 28.10.2025 | Production problem | Haloperidol-neuraxpharm decanoate 100 mg/ml |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 28.10.2025 | Other | Quetiapine-neuraxpharm 50 mg prolonged-release tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 28.10.2025 | Other | Quetiapine-neuraxpharm 150 mg prolonged-release tablets |
| Flutamide | Change notification | 28.10.2025 | Other | Flutamide AL 250 |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 28.10.2025 | Other | Quetiapine-neuraxpharm 200 mg prolonged-release tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 28.10.2025 | Other | Quetiapine-neuraxpharm 300 mg prolonged-release tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 28.10.2025 | Other | Quetiapine-neuraxpharm 400 mg prolonged-release tablets |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 28.10.2025 | Other | Quetiapine-neuraxpharm 600 mg prolonged-release tablets |
| Biperiden hydrochloride | Change notification | 28.10.2025 | Production problem | Biperiden-neuraxpharm 2 mg |
| Biperiden hydrochloride | Change notification | 28.10.2025 | Production problem | Biperiden-neuraxpharm 4 mg |
| Methylphenidate hydrochloride | Change notification | 28.10.2025 | Other | Methylphenidate hydrochloride-neuraxpharm 27 mg prolonged-release tablets |
| Sodium (methylprednisolone-21-succinate) | Change notification | 28.10.2025 | Other | Urbason soluble forte 1000 mg |
| Isosorbide mononitrate | Change notification | 28.10.2025 | Production problem | ISMN STADA 50 mg hard capsules, delayed release |
| Aprepitant | Change notification | 28.10.2025 | Production problem | Aprepitant STADA 125 mg and 80 mg hard capsules |
| Pramipexole dihydrochloride monohydrate | Change notification | 28.10.2025 | Production problem | Pramipexole STADA 0.52 mg prolonged-release tablets |
| Aprepitant | Change notification | 28.10.2025 | Production problem | Aprepitant STADA 80 mg hard capsules |
| Aprepitant | Change notification | 28.10.2025 | Production problem | Aprepitant STADA 125 mg hard capsules |
| Gabapentin | Change notification | 27.10.2025 | Other | Gabapentin Holsten 100 mg hard capsules |
| Tetrabenazine | Initial report | 27.10.2025 | Other | Tetrabenazine Aristo 25 mg tablets |
| Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) | Change notification | 27.10.2025 | Other | Ferrlecit 62.5 mg |
| Cefaclor monohydrate | Change notification | 27.10.2025 | Other | Cefaclor 125 TS – 1 A Pharma |
| Methyldopa (Ph.Eur.) | Change notification | 27.10.2025 | Other | Dopegyt tablets |
| Insulin glargine | Change notification | 27.10.2025 | Other | Semglee 100 units/ml solution for injection in pre-filled pen – OP(5x3ml) |
| Sufentanil citrate | Initial report | 27.10.2025 | Production problem | Sufenta mite |
| Arsenic(III) oxide | Change notification | 27.10.2025 | Production problem | Arsenic trioxide STADA 1 mg/ml concentrate for solution for infusion |